THC
21
5
7
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (21)
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Tetrahydrocannabinol (THC) and Sleep
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
Modulation of THC Effects by CBD: a Dose-ranging Study
Pilot fMRI Studies of Aging-Related Effects of THC
THC Titration of High-Potency Cannabis Concentrates
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks
Behavioral Pharmacology of THC and Alpha-pinene
Behavioral Pharmacology of Orally Administered THC and D-limonene
THC Memory & Reward Learning Pilot
THC Crossover Study
Age-Related Effects of THC
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
Characterization of the Pharmacodynamic Response to Vaped THC
Do Adolescents and Adults Differ in Their Acute Response to Cannabis?